|
|
|
Insider
Information: |
Pasternak Andy |
Relationship: |
EVP, Chief Strategy Of... |
City: |
Dublin |
State: |
L2 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Horizon Pharma, Inc. |
HZNP |
EVP, Chief Strategy Of... |
2023-10-06 |
0 |
2020-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HZNP |
Horizon Pharma, Inc. |
EVP, Chief Strategy Officer |
|
2023-10-06 |
4 |
D |
$116.50 |
$6,563,377 |
D/D |
(56,338) |
0 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP, Chief Strategy Officer |
|
2023-01-17 |
4 |
AS |
$113.03 |
$3,066,323 |
D/D |
(27,129) |
56,338 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP, Chief Strategy Officer |
|
2022-12-30 |
4 |
D |
$113.80 |
$4,473,819 |
D/D |
(39,313) |
83,467 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP, Chief Strategy Officer |
|
2022-12-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
88,733 |
122,780 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP, Chief Strategy Officer |
|
2022-12-13 |
4 |
S |
$112.60 |
$3,397,171 |
D/D |
(30,169) |
34,047 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP, Chief Strategy Officer |
|
2022-12-13 |
4 |
OE |
$29.52 |
$686,370 |
D/D |
23,251 |
64,216 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2022-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,421 |
46,468 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2022-11-01 |
4 |
D |
$63.18 |
$347,680 |
D/D |
(5,503) |
40,965 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2022-07-29 |
4 |
AS |
$82.44 |
$400,483 |
D/D |
(4,850) |
34,047 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2022-06-10 |
4 |
AS |
$85.36 |
$65,044 |
D/D |
(762) |
38,897 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2022-02-18 |
4 |
AS |
$94.82 |
$124,499 |
D/D |
(1,313) |
39,659 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2022-01-06 |
4 |
AS |
$97.30 |
$795,296 |
D/D |
(7,987) |
40,972 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2022-01-05 |
4 |
D |
$101.84 |
$2,210,946 |
D/D |
(21,710) |
48,959 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2022-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
48,839 |
70,669 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2021-12-07 |
4 |
AS |
$100.00 |
$152,500 |
D/D |
(1,525) |
21,830 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2021-11-04 |
4 |
AS |
$110.64 |
$3,410,181 |
D/D |
(30,168) |
23,355 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2021-11-04 |
4 |
OE |
$29.52 |
$686,370 |
D/D |
23,251 |
53,523 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2021-11-01 |
4 |
D |
$118.29 |
$650,950 |
D/D |
(5,503) |
30,272 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2021-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,421 |
35,775 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2021-09-09 |
4 |
AS |
$107.83 |
$2,507,261 |
D/D |
(23,250) |
23,354 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2021-09-09 |
4 |
OE |
$29.52 |
$686,340 |
D/D |
23,250 |
46,604 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2021-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,708 |
27,212 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2021-07-28 |
4 |
D |
$102.50 |
$395,445 |
D/D |
(3,858) |
23,354 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2021-02-17 |
4 |
D |
$87.17 |
$91,093 |
D/D |
(1,045) |
17,742 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP and Chief Business Officer |
|
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,358 |
18,787 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|